Luo Ying
- SEC CIK
- 0001959160
In the past year, 1 open-market sale filing worth $82.9K and no purchases.
Current role at each company
- GYRE Gyre Therapeutics, Inc.Chief Executive Officeras of Jun 10, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $82.9K
- 1 filing
- Net
- −$82.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Luo Ying as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 (view filing) | May 5-6 | 2 days | Luo YingChief Executive Officer | SSale | −10.3K | $8.04 | −$82.9K | −0.4%2.57M after | 2 lots10b5-1 |